Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1993 Feb;48(2):176–182. doi: 10.1136/thx.48.2.176

New perspectives on basic mechanisms in lung disease. 3. Drug intervention in asthma: present and future.

V A Alabaster 1, B A Moore 1
PMCID: PMC464303  PMID: 8493636

Full text

PDF
176

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander A. G., Barnes N. C., Kay A. B. Trial of cyclosporin in corticosteroid-dependent chronic severe asthma. Lancet. 1992 Feb 8;339(8789):324–328. doi: 10.1016/0140-6736(92)91646-p. [DOI] [PubMed] [Google Scholar]
  2. Barnes P. J. A new approach to the treatment of asthma. N Engl J Med. 1989 Nov 30;321(22):1517–1527. doi: 10.1056/NEJM198911303212206. [DOI] [PubMed] [Google Scholar]
  3. Barnes P. J. Asthma. New therapeutic approaches. Br Med Bull. 1992 Jan;48(1):231–247. doi: 10.1093/oxfordjournals.bmb.a072538. [DOI] [PubMed] [Google Scholar]
  4. Barnes P. J. Biochemistry of asthma. Trends Biochem Sci. 1991 Oct;16(10):365–369. doi: 10.1016/0968-0004(91)90152-l. [DOI] [PubMed] [Google Scholar]
  5. Barnes P. J., Chung K. F., Page C. P. Platelet-activating factor as a mediator of allergic disease. J Allergy Clin Immunol. 1988 May;81(5 Pt 1):919–934. doi: 10.1016/0091-6749(88)90952-9. [DOI] [PubMed] [Google Scholar]
  6. Barnes P. J. Effect of corticosteroids on airway hyperresponsiveness. Am Rev Respir Dis. 1990 Feb;141(2 Pt 2):S70–S76. [PubMed] [Google Scholar]
  7. Beasley R. C., Featherstone R. L., Church M. K., Rafferty P., Varley J. G., Harris A., Robinson C., Holgate S. T. Effect of a thromboxane receptor antagonist on PGD2- and allergen-induced bronchoconstriction. J Appl Physiol (1985) 1989 Apr;66(4):1685–1693. doi: 10.1152/jappl.1989.66.4.1685. [DOI] [PubMed] [Google Scholar]
  8. Beavo J. A., Reifsnyder D. H. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol Sci. 1990 Apr;11(4):150–155. doi: 10.1016/0165-6147(90)90066-H. [DOI] [PubMed] [Google Scholar]
  9. Braquet P., Touqui L., Shen T. Y., Vargaftig B. B. Perspectives in platelet-activating factor research. Pharmacol Rev. 1987 Jun;39(2):97–145. [PubMed] [Google Scholar]
  10. Carter G. W., Young P. R., Albert D. H., Bouska J., Dyer R., Bell R. L., Summers J. B., Brooks D. W. 5-lipoxygenase inhibitory activity of zileuton. J Pharmacol Exp Ther. 1991 Mar;256(3):929–937. [PubMed] [Google Scholar]
  11. Chung K. F., Barnes P. J. PAF antagonists. Their potential therapeutic role in asthma. Drugs. 1988 Feb;35(2):93–103. doi: 10.2165/00003495-198835020-00001. [DOI] [PubMed] [Google Scholar]
  12. Cockcroft D. W. Therapy for airway inflammation in asthma. J Allergy Clin Immunol. 1991 May;87(5):914–919. doi: 10.1016/0091-6749(91)90412-h. [DOI] [PubMed] [Google Scholar]
  13. Corrigan C. J., Kay A. B. Asthma. Role of T-lymphocytes and lymphokines. Br Med Bull. 1992 Jan;48(1):72–84. doi: 10.1093/oxfordjournals.bmb.a072543. [DOI] [PubMed] [Google Scholar]
  14. Daffos F., Forestier F., Grangeot-Keros L., Capella Pavlovsky M., Lebon P., Chartier M., Pillot J. Prenatal diagnosis of congenital rubella. Lancet. 1984 Jul 7;2(8393):1–3. doi: 10.1016/s0140-6736(84)91993-7. [DOI] [PubMed] [Google Scholar]
  15. Dahlén S. E., Hedqvist P., Hammarström S., Samuelsson B. Leukotrienes are potent constrictors of human bronchi. Nature. 1980 Dec 4;288(5790):484–486. doi: 10.1038/288484a0. [DOI] [PubMed] [Google Scholar]
  16. Delespesse G., Sarfati M., Wu C. Y., Fournier S., Letellier M. The low-affinity receptor for IgE. Immunol Rev. 1992 Feb;125:77–97. doi: 10.1111/j.1600-065x.1992.tb00626.x. [DOI] [PubMed] [Google Scholar]
  17. Ford-Hutchinson A. W. FLAP: a novel drug target for inhibiting the synthesis of leukotrienes. Trends Pharmacol Sci. 1991 Feb;12(2):68–70. doi: 10.1016/0165-6147(91)90500-r. [DOI] [PubMed] [Google Scholar]
  18. Geddes D. M. Inhaled corticosteroids: benefits and risks. Thorax. 1992 Jun;47(6):404–407. doi: 10.1136/thx.47.6.404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Giembycz M. A. Could isoenzyme-selective phosphodiesterase inhibitors render bronchodilator therapy redundant in the treatment of bronchial asthma? Biochem Pharmacol. 1992 May 28;43(10):2041–2051. doi: 10.1016/0006-2952(92)90160-k. [DOI] [PubMed] [Google Scholar]
  20. Hoag J. E., McFadden E. R., Jr Long-term effect of cromolyn sodium on nonspecific bronchial hyperresponsiveness: a review. Ann Allergy. 1991 Jan;66(1):53–63. [PubMed] [Google Scholar]
  21. Iwamoto I., Ra C., Sato T., Tomioka H., Yoshida S. Thromboxane A2 production in allergen-induced immediate and late asthmatic responses. Its possible role in inducing the late response. J Asthma. 1988;25(3):117–124. doi: 10.3109/02770908809073198. [DOI] [PubMed] [Google Scholar]
  22. Kay A. B., Corrigan C. J. Asthma. Eosinophils and neutrophils. Br Med Bull. 1992 Jan;48(1):51–64. doi: 10.1093/oxfordjournals.bmb.a072541. [DOI] [PubMed] [Google Scholar]
  23. Kinet J. P., Blank U., Brini A., Jouvin M. H., Küster H., Mejan O., Ra C. The high-affinity receptor for immunoglobulin E: a target for therapy of allergic diseases. Int Arch Allergy Appl Immunol. 1991;94(1-4):51–55. doi: 10.1159/000235323. [DOI] [PubMed] [Google Scholar]
  24. König P. Inhaled corticosteroids--their present and future role in the management of asthma. J Allergy Clin Immunol. 1988 Aug;82(2):297–306. doi: 10.1016/0091-6749(88)91015-9. [DOI] [PubMed] [Google Scholar]
  25. Laitinen L. A., Heino M., Laitinen A., Kava T., Haahtela T. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis. 1985 Apr;131(4):599–606. doi: 10.1164/arrd.1985.131.4.599. [DOI] [PubMed] [Google Scholar]
  26. Löfdahl C. G., Chung K. F. Long-acting beta 2-adrenoceptor agonists: a new perspective in the treatment of asthma. Eur Respir J. 1991 Feb;4(2):218–226. [PubMed] [Google Scholar]
  27. Manning P. J., Watson R. M., Margolskee D. J., Williams V. C., Schwartz J. I., O'Byrne P. M. Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist. N Engl J Med. 1990 Dec 20;323(25):1736–1739. doi: 10.1056/NEJM199012203232504. [DOI] [PubMed] [Google Scholar]
  28. Phillipps G. H. Structure-activity relationships of topically active steroids: the selection of fluticasone propionate. Respir Med. 1990 Nov;84 (Suppl A):19–23. doi: 10.1016/s0954-6111(08)80003-0. [DOI] [PubMed] [Google Scholar]
  29. Rochester C. L., Rankin J. A. Is asthma T-cell mediated? Am Rev Respir Dis. 1991 Nov;144(5):1005–1007. doi: 10.1164/ajrccm/144.5.1005. [DOI] [PubMed] [Google Scholar]
  30. Romagnani S. Regulation and deregulation of human IgE synthesis. Immunol Today. 1990 Sep;11(9):316–321. doi: 10.1016/s0167-5699(10)80004-0. [DOI] [PubMed] [Google Scholar]
  31. Schleimer R. P. Effects of glucocorticosteroids on inflammatory cells relevant to their therapeutic applications in asthma. Am Rev Respir Dis. 1990 Feb;141(2 Pt 2):S59–S69. [PubMed] [Google Scholar]
  32. Stevens R. L., Austen K. F. Recent advances in the cellular and molecular biology of mast cells. Immunol Today. 1989 Nov;10(11):381–386. doi: 10.1016/0167-5699(89)90272-7. [DOI] [PubMed] [Google Scholar]
  33. Szefler S. J. Glucocorticoid therapy for asthma: clinical pharmacology. J Allergy Clin Immunol. 1991 Aug;88(2):147–165. doi: 10.1016/0091-6749(91)90323-g. [DOI] [PubMed] [Google Scholar]
  34. Tattersfield A. E. Asthma. Bronchodilators: new developments. Br Med Bull. 1992 Jan;48(1):190–204. doi: 10.1093/oxfordjournals.bmb.a072534. [DOI] [PubMed] [Google Scholar]
  35. Toogood J. H. Complications of topical steroid therapy for asthma. Am Rev Respir Dis. 1990 Feb;141(2 Pt 2):S89–S96. [PubMed] [Google Scholar]
  36. Wegner C. D., Gundel R. H., Reilly P., Haynes N., Letts L. G., Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science. 1990 Jan 26;247(4941):456–459. doi: 10.1126/science.1967851. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES